-
Signature
-
/s/ Matthew Gilmartin, Attorney-in-Fact for W. Richard Staub
-
Stock symbol
-
IQV
-
Transactions as of
-
Feb 10, 2022
-
Transactions value $
-
$0
-
Form type
-
4
-
Date filed
-
2/14/2022, 04:09 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
IQV |
Common Stock |
Award |
$0 |
+1.47K |
+5.56% |
$0.00 |
27.8K |
Feb 10, 2022 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
IQV |
Stock Appreciation Right |
Award |
$0 |
+5.46K |
|
$0.00 |
5.46K |
Feb 10, 2022 |
Common Stock |
5.46K |
$250.43 |
Direct |
F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
President, Research & Development Solutions